BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30155912)

  • 21. A new approach to hierarchical data analysis: Targeted maximum likelihood estimation for the causal effect of a cluster-level exposure.
    Balzer LB; Zheng W; van der Laan MJ; Petersen ML
    Stat Methods Med Res; 2019 Jun; 28(6):1761-1780. PubMed ID: 29921160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weighting in instrumental variables and G-estimation.
    Joffe MM; Brensinger C
    Stat Med; 2003 Apr; 22(8):1285-303. PubMed ID: 12687655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes.
    Elliott MR; Raghunathan TE; Li Y
    Biostatistics; 2010 Apr; 11(2):353-72. PubMed ID: 20101045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a curse of dimensionality appropriate (CODA) asymptotic theory for semi-parametric models.
    Robins JM; Ritov Y
    Stat Med; 1997 Jan 15-Feb 15; 16(1-3):285-319. PubMed ID: 9004398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of generalized linear mixed model procedures with estimating equations for variance and covariance parameter estimation in longitudinal studies and group randomized trials.
    Evans BA; Feng Z; Peterson AV
    Stat Med; 2001 Nov; 20(22):3353-73. PubMed ID: 11746323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the causal effect of compliance on binary outcome in randomized controlled trials.
    Goetghebeur E; Molenberghs G; Katz J
    Stat Med; 1998 Feb; 17(3):341-55. PubMed ID: 9493258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mendelian randomization using semiparametric linear transformation models.
    Huang YT
    Stat Med; 2020 Mar; 39(7):890-905. PubMed ID: 31879996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model selection criterion for causal parameters in structural mean models based on a quasi-likelihood.
    Taguri M; Matsuyama Y; Ohashi Y
    Biometrics; 2014 Sep; 70(3):721-30. PubMed ID: 24621405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mendelian randomization as an instrumental variable approach to causal inference.
    Didelez V; Sheehan N
    Stat Methods Med Res; 2007 Aug; 16(4):309-30. PubMed ID: 17715159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the causal effect of randomization versus treatment preference in a doubly randomized preference trial.
    Marcus SM; Stuart EA; Wang P; Shadish WR; Steiner PM
    Psychol Methods; 2012 Jun; 17(2):244-54. PubMed ID: 22563844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two robust tools for inference about causal effects with invalid instruments.
    Kang H; Lee Y; Cai TT; Small DS
    Biometrics; 2022 Mar; 78(1):24-34. PubMed ID: 33616910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causal inference in survival analysis using pseudo-observations.
    Andersen PK; Syriopoulou E; Parner ET
    Stat Med; 2017 Jul; 36(17):2669-2681. PubMed ID: 28384840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomization inference for treatment effects on a binary outcome.
    Rigdon J; Hudgens MG
    Stat Med; 2015 Mar; 34(6):924-35. PubMed ID: 25471299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint mixed-effects models for causal inference with longitudinal data.
    Shardell M; Ferrucci L
    Stat Med; 2018 Feb; 37(5):829-846. PubMed ID: 29205454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The compliance score as a regressor in randomized trials.
    Joffe MM; Ten Have TR; Brensinger C
    Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring and estimating treatment effect on dichotomous outcome of a population.
    Wang X; Jin Y; Yin L
    Stat Methods Med Res; 2016 Oct; 25(5):1779-1790. PubMed ID: 24004484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of causal effects in the presence of nonignorable missing outcome values.
    Mattei A; Mealli F; Pacini B
    Biometrics; 2014 Jun; 70(2):278-88. PubMed ID: 24447366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.